http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109078047-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-782 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-333 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-605 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L5-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-9789 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L5-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-9789 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-605 |
filingDate | 2018-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-109078047-B |
titleOfInvention | Preparation and application of effective part with tyrosinase inhibition effect in cortex mori |
abstract | The invention discloses preparation and application of an effective part with tyrosinase inhibition effect in cortex mori radicis, belonging to the technical field of medicines, skin care products and foods. The effective parts with tyrosinase inhibition effect in the cortex mori radicis provided by the invention comprise a 50% ethanol elution part and a 70% ethanol elution part, wherein the flavonoid compounds at the 50% ethanol elution part are sanggenon T, sanggenon L, sanggenon G and sanggenon O, and the flavonoid compounds at the 70% ethanol elution part are sanggenon L, sanggenon O, sanggenon G, sanggenon E, sanggenon T, 5' -geranyl-5,7,2',4' -tetrahydroxyflavone and sanggenon V. The effective part with tyrosinase inhibition effect can be effectively used for inhibiting enzymatic browning of fruits and vegetables, whitening in cosmetics, and preventing and treating human body pigmentation diseases and melanoma caused by excessive melanin and preparing medicines for treating diseases requiring tyrosinase activity inhibition. |
priorityDate | 2018-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 127.